U.S. Biotech company CohBar develops mitochondria-based therapeutics for age-related diseases

3 years ago
1.36K

U.S. biotech company CohBar is developing mitochondria-based therapeutics for age-related diseases. One America’s Stephanie Myers spoke with CohBar CEO Steven Engle about the progress and clinical programs they are developing to combat these diseases.

Loading 10 comments...